ADMA

ADMA Biologics Inc Common Stock (ADMA)

Stock · NASDAQ · Health Care

$9.34as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$8.22
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

ADMA Biologics Inc Common Stock Competitors

Chosen by industry and closest market cap.

  • ADMA
    ADMA Biologics Inc Common Stock
    $9.34
    ▼ 1.48%
    Market cap $2.34BP/E
  • COAG
    Hemab Therapeutics Holdings Inc. Common Stock
    $44.77
    ▼ 9.55%
    Market cap $2.44BP/E
    $23$55.42
  • MESO
    Mesoblast Limited American Depositary Shares
    $17.42
    ▼ 4.18%
    Market cap $2.02BP/E
    $1.88$3.31
  • TARS
    Tarsus Pharmaceuticals Inc. Common Stock
    $71.84
    ▼ 0.12%
    Market cap $2.81BP/E
    $48.2$85.25
  • BEAM
    Beam Therapeutics Inc. Common Stock
    $29.31
    ▼ 3.84%
    Market cap $2.81BP/E
    $16.02$38.26
  • KOD
    Kodiak Sciences Inc Common Stock
    $37.77
    ▼ 3.45%
    Market cap $2.84BP/E
    $8.29$47.84
  • RXRX
    Recursion Pharmaceuticals Inc. Class A Common Stock
    $3.33
    ▼ 3.20%
    Market cap $1.69BP/E
    $2.77$7.18

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
209.07M
Total value held
$1.82B
Institutional holders
350
Top holders this quarter
  • Unknown36.83M
  • Unknown14.08M
  • Unknown11.19M
  • Unknown10.31M
  • Unknown6.25M
  • Unknown6.10M
  • Unknown5.82M
  • Unknown5.06M
  • Unknown5.01M
  • Unknown4.79M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.